Neuropsycholgy and Neuroimaging in Transient Global Amnesia
NCT ID: NCT02562560
Last Updated: 2020-09-01
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
60 participants
INTERVENTIONAL
2008-09-30
2015-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Longitudinal Monitoring of Cerebral Connectivity 3T MRI in Patients With a Transcient Global Amnesia
NCT02796287
Transient Global Amnesia (TGA). Exploratory Study of the Default Mode Network During the Acute Phase
NCT02010853
Correlation Between Cognition and Neuroimaging in TIA Patients
NCT04989608
Amyloid PET in Patients With Mild Cognitive Impairment and Early Dementia
NCT06402370
Study of the Indications for Amyloid Positon Emission Tomography (PET) Scans and Their Usefulness for Patients With Suspected Alzheimer's Disease (AD)
NCT06467981
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
DIAGNOSTIC
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
TGA
Neuropsychological tests
Cerebral imaging (MRI, PET-FDG)
Controls
Neuropsychological tests
Cerebral imaging (MRI, PET-FDG)
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Neuropsychological tests
Cerebral imaging (MRI, PET-FDG)
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Minimum of 7 years of education
* French native speaker
* Healthy subjects : Non pathological Dementia rating scale score
* Patients : Clinical diagnosis of TGA according to Hodges and Warlow's criterion
Exclusion Criteria
* Encephalitis
* Endocrinal disease
* Hepatic disease
* Case history of head injury with loss of consciousness of more than one hour
* Case history of stroke
* Case history of cancer during the five last years except squamous cell carcinomas
* Alcoholism or drug addiction
* Major psychiatric disorders according the Diagnostic and Statistical Manual of -Mental Disorders
30 Years
90 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Caen
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Fausto Viader, PUPH
Role: PRINCIPAL_INVESTIGATOR
University Hospital, Caen
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2007-A00910-53
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.